FDA Inspection 1247503 — Anipro/Xtraformance Feeds - AL006
The FDA completed an inspection of Anipro/Xtraformance Feeds - AL006 on August 7, 2024 in Louisville, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 7, 2024
- Fiscal Year
- 2024
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Louisville, AL (United States)